Gilead Sciences
GILD
#105
Rank
$182.89 B
Marketcap
$147.50
Share price
-1.04%
Change (1 day)
32.70%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of June 2026 : $11.74 Billion USD

According to Gilead Sciences's latest financial reports the company has $11.74 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$22.61 B17.52%
2024-12-31$$19.24 B-15.4%
2023-12-31$$22.74 B7.26%
2022-12-31$$21.20 B0.69%
2021-12-31$$21.06 B15.6%
2020-12-31$$18.22 B-19.55%
2019-12-31$$22.65 B5.18%
2018-12-31$$21.53 B5.04%
2017-12-31$$20.50 B5.88%
2016-12-31$$19.36 B1.31%
2015-12-31$$19.11 B20.82%
2014-12-31$$15.81 B34.69%
2013-12-31$$11.74 B23.07%
2012-12-31$$9.54 B38.97%
2011-12-31$$6.86 B12.18%
2010-12-31$$6.12 B-5.89%
2009-12-31$$6.50 B45.67%
2008-12-31$$4.46 B24.03%
2007-12-31$$3.60 B92.65%
2006-12-31$$1.86 B-38.28%
2005-12-31$$3.02 B61.84%
2004-12-31$$1.87 B86.53%
2003-12-31$$1.00 B75.55%
2002-12-31$$0.57 B26.28%
2001-12-31$$0.45 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$84.97 B 623.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$85.49 B 627.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-$5.89 Billion-150.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$33.87 B 188.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$11.68 B-0.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$18.84 B 60.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$2.67 B-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$20.24 B 72.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$41.98 B 257.49%๐Ÿ‡บ๐Ÿ‡ธ USA